Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia

NCT00645944 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00645944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00645944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2008
Completion date
April 30, 2011
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, schizoaffective disorder, schizophrenia, sleep disorders